Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Inflammatory Bowel Disease
•
General Rheumatology
•
Gastroenterology
•
TNF inhibitor
•
Immunosuppression
•
Anaphylaxis
In patients with history of anaphylaxis to a TNF inhibitor, are you comfortable trying an alternative TNF inhibitor?
Related Questions
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
What are your vaccine recommendations while patients are on biologics?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
In an infant whose mother resumes TNF inhibitor therapy (e.g., adalimumab, infliximab, certolizumab) after delivery and is breastfeeding, do you recommend delaying live vaccinations?
Have you utilized JAK inhibitors in patients on dialysis?
How would you approach management of a patient with mixed cryoglobulinemic vasculitis with predominant skin involvement and no major organ involvement?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
How would you approach management of an elderly patient with known mantle cell lymphoma and new diagnosis of cryoglobulinemic vasculitis with mild skin involvement, fatigue, arthralgias but no other major organ involvement?
What sampling techniques do you use to improve the diagnostic yield of biopsies in a patient with suspected vasculitis and extensive scattered ulceration throughout the GI tract?
